Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer - Top-Institutions - MDSpire

Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer

  • By

  • Shu-Qing Yang

  • Hui Yu

  • Yu-Long Yang

  • Cheng Wang

  • Yan Li

  • Di-Feng Guo

  • Chen-Shi Lin

  • Chao Li

  • Zhi-Qiang Cai

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Radiation Oncology

  • #2

    University of Colorado Anschutz Medical Campus/UCHealth University of Colorado Hospital
    University of Colorado Anschutz Medical Campus/UCHealth University of Colorado Hospital

    Aurora, Colorado

    Key Differentiators

    • Radiation Oncology

  • #3

    Early Lung Cancer Action Program (ELCAP)
    Early Lung Cancer Action Program (ELCAP)

    New York, New York

    Key Differentiators

    • Radiation Oncology

  • #4

    Erasmus University Medical Center
    Erasmus University Medical Center

    Rotterdam, Netherlands

    Key Differentiators

    • Radiation Oncology

  • #5

    The Royal Marsden Hospital
    The Royal Marsden Hospital

    London, United Kingdom

    Key Differentiators

    • Radiation Oncology

Original Source(s)

Four-dimensional computed tomography ventilation imaging-guided radiotherapy planning in different techniques for lung cancer

  • by Shu-Qing Yang, Hui Yu, Yu-Long Yang, Cheng Wang, Yan Li, Di-Feng Guo, Chen-Shi Lin, Chao Li, Zhi-Qiang Cai

  • June 1, 2026

Related Content

Prognostic significance of ypN status after neoadjuvant chemoimmunotherapy in resectable NSCLC: a systematic review and meta-analysis

Efficacy of IoT-based perioperative respiratory rehabilitation for lung resection: Protocol of a randomized controlled trial

Gene amplification in the premalignant stages of non-small cell lung cancer development